Regulation of Cystathionine γ-Lyase Expression in the Cardiovascular System: Insights into Exogenous Hydrogen Sulfide, Hydrogen Peroxide, Hypoxia, and Nuclear Factor kB Signaling

Main Article Content

Maoxian Wang

Abstract

Cystathionine γ-lyase is a key enzyme in the transsulfuration pathway responsible for endogenous hydrogen sulfide production in the cardiovascular system. As the third gaseous signaling molecule, hydrogen sulfide plays crucial roles in maintaining vascular homeostasis, regulating vasodilation, and protecting against ischemia-reperfusion injury. This review comprehensively analyzes the regulatory mechanisms governing cystathionine γ-lyase expression under various physiological and pathological conditions. Exogenous hydrogen sulfide exhibits concentration-dependent bidirectional regulation of cystathionine γ-lyase expression, with lower concentrations (10-80 μM) suppressing cystathionine γ-lyase through feedback inhibition, while higher concentrations (120-160 μM) upregulating its expression as a protective response. Hydrogen peroxide , at moderate concentrations (5 μM), significantly enhances cystathionine γ-lyase promoter activity and mRNA/protein expression, suggesting a potential feedback loop where cystathionine γ-lyase -derived hydrogen sulfide scavenges reactive oxygen species. Hypoxia regulates cystathionine γ-lyase through transcriptional and post-transcriptional mechanisms, with increased cystathionine γ-lyase expression potentially protecting cells by elevating hydrogen sulfide levels and buffering oxygen consumption. Furthermore, lipopolysaccharide-induced cystathionine γ-lyase expression critically depends on the Nuclear Factor κB transcription factor binding site (GGACATTCC) within the cystathionine γ-lyase promoter, establishing a direct link between inflammatory signaling and hydrogen sulfide biosynthesis. Based on these findings, we propose a mechanistic hypothesis wherein hypoxia-induced cardiomyocyte apoptosis releases hydrogen peroxide, which activates Nuclear Factor κB signaling in vascular endothelial cells to upregulate cystathionine γ-lyase expression, leading to enhanced hydrogen sulfide production and subsequent vasodilation. Understanding these regulatory networks provides theoretical foundations for developing therapeutic strategies targeting the cystathionine γ-lyase/hydrogen sulfide pathway in cardiovascular diseases, including myocardial infarction, hypertension, and atherosclerosis.


Keywords: Cystathionine γ-lyase; Hydrogen sulfide; Hypoxia; Nuclear Factor κB; Cardiovascular regulation

Keywords: Cystathionine gamma-lyase, Hydrogen sulfide, Hypoxia, Nuclear Factor kappaB, Cardiovascular regulation

Article Details

How to Cite
WANG, Maoxian. Regulation of Cystathionine γ-Lyase Expression in the Cardiovascular System: Insights into Exogenous Hydrogen Sulfide, Hydrogen Peroxide, Hypoxia, and Nuclear Factor kB Signaling. Medical Research Archives, [S.l.], v. 14, n. 4, may 2026. ISSN 2375-1924. Available at: <https://esmed.org/MRA/mra/article/view/7409>. Date accessed: 24 june 2026. doi: https://doi.org/10.18103/mra.v14i4.7409.
Keywords
Cystathionine ?-lyase; Hydrogen sulfide; Hypoxia; NF-?B; Cardiovascular regulation
Section
Review Articles

References

1. Wang, R. The gasotransmitter role of hydrogen sulfide. Antioxid Redox Signal 5, 493-501 (2003).
2. Kimura, H. Hydrogen sulfide: its production and functions. Exp Physiol 96, 833-835 (2011).
3. Enokido, Y., et al. Cystathionine beta-synthase, a key enzyme for homocysteine metabolism, is preferentially expressed in the radial glia/astrocyte lineage of developing mouse CNS. FASEB J 19, 1854-1856 (2005).
4. Shibuya, N., et al. 3-Mercaptopyruvate sulfurtransferase produces hydrogen sulfide and bound sulfane sulfur in the brain. Antioxid Redox Signal 11, 703-714 (2009).
5. Yang, G., et al. Cystathionine gamma-lyase deficiency and overproliferation of smooth muscle cells. Cardiovascular research 86, 487-495 (2010).
6. Xu, M., et al. Hydrogen sulfide: Recent progress and perspectives for the treatment of dermatological diseases. J Adv Res 27, 11-17 (2021).
7. Gall, T., et al. Overview on hydrogen sulfide-mediated suppression of vascular calcification and hemoglobin/heme-mediated vascular damage in atherosclerosis. Redox Biol 57, 102504 (2022).
8. Yan, S.K., et al. Effects of hydrogen sulfide on homocysteine-induced oxidative stress in vascular smooth muscle cells. Biochem Biophys Res Commun 351, 485-491 (2006).
9. Yang, G., Wu, L. & Wang, R. Pro-apoptotic effect of endogenous H2S on human aorta smooth muscle cells. FASEB J 20, 553-555 (2006).
10. Elrod, J.W., et al. Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc Natl Acad Sci U S A 104, 15560-15565 (2007).
11. Yang, G., et al. H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science 322, 587-590 (2008).
12. Zhang, J., Xie, Y., Xu, Y., Pan, Y. & Shao, C. Hydrogen sulfide contributes to hypoxia-induced radioresistance on hepatoma cells. J Radiat Res 52, 622-628 (2011).
13. Alshahwan, H., et al. Hydrogen sulfide donor GYY4137 attenuates vascular complications in mesenteric bed of streptozotocin-induced diabetic rats. Eur J Pharmacol 933, 175265 (2022).
14. Beltowski, J. & Kowalczyk-Boltuc, J. Hydrogen sulfide in the experimental models of arterial hypertension. Biochem Pharmacol 208, 115381 (2023).
15. Geng, B., et al. H2S generated by heart in rat and its effects on cardiac function. Biochemical and biophysical research communications 313, 362-368 (2004).
16. Osmond, J.M. & Kanagy, N.L. Modulation of hydrogen sulfide by vascular hypoxia. Hypoxia (Auckl) 2, 117-126 (2014).
17. Pushpakumar, S., Kundu, S. & Sen, U. Endothelial dysfunction: the link between homocysteine and hydrogen sulfide. Curr Med Chem 21, 3662-3672 (2014).
18. Kimura, H. Signaling molecules: hydrogen sulfide and polysulfide. Antioxid Redox Signal 22, 362-376 (2015).
19. Sabino, J.P., Traslavina, G.A. & Branco, L.G. Role of central hydrogen sulfide on ventilatory and cardiovascular responses to hypoxia in spontaneous hypertensive rats. Respir Physiol Neurobiol 231, 21-27 (2016).
20. Leucker, T.M., et al. Cystathionine gamma-lyase protects vascular endothelium: a role for inhibition of histone deacetylase 6. Am J Physiol Heart Circ Physiol 312, H711-H720 (2017).
21. Webb, G.D., et al. Contractile and vasorelaxant effects of hydrogen sulfide and its biosynthesis in the human internal mammary artery. J Pharmacol Exp Ther 324, 876-882 (2008).
22. Ariyaratnam, P., Loubani, M. & Morice, A.H. Hydrogen sulphide vasodilates human pulmonary arteries: a possible role in pulmonary hypertension? Microvasc Res 90, 135-137 (2013).
23. Materazzi, S., et al. Vasodilator activity of hydrogen sulfide (H(2)S) in human mesenteric arteries. Microvasc Res 109, 38-44 (2017).
24. Cacanyiova, S., et al. Nitroso-sulfide coupled signaling triggers specific vasoactive effects in the intrarenal arteries of patients with arterial hypertension. J Physiol Pharmacol 68, 527-538 (2017).
25. Cindrova-Davies, T., et al. Reduced cystathionine gamma-lyase and increased miR-21 expression are associated with increased vascular resistance in growth-restricted pregnancies: hydrogen sulfide as a placental vasodilator. Am J Pathol 182, 1448-1458 (2013).
26. Wang, M., Guo, Z. & Wang, S. Regulation of cystathionine gamma-lyase in mammalian cells by hypoxia. Biochem Genet 52, 29-37 (2014).
27. Tran, B.H., et al. Cardioprotective effects and pharmacokinetic properties of a controlled release formulation of a novel hydrogen sulfide donor in rats with acute myocardial infarction. Biosci Rep 35(2015).
28. Mistry, R.K., et al. Transcriptional Regulation of Cystathionine-gamma-Lyase in Endothelial Cells by NADPH Oxidase 4-Dependent Signaling. J Biol Chem 291, 1774-1788 (2016).
29. Magierowski, M., et al. Exogenous and Endogenous Hydrogen Sulfide Protects Gastric Mucosa against the Formation and Time-Dependent Development of Ischemia/Reperfusion-Induced Acute Lesions Progressing into Deeper Ulcerations. Molecules 22(2017).
30. Sun, H., Qi, L., Wang, S., Li, X. & Li, C. Hydrogen sulfide is expressed in the human and the rat cultured nucleus pulposus cells and suppresses apoptosis induced by hypoxia. PLoS One 13, e0192556 (2018).
31. Wu, B., et al. Interaction of Hydrogen Sulfide with Oxygen Sensing under Hypoxia. Oxid Med Cell Longev 2015, 758678 (2015).
32. Lu, M., et al. MicroRNA-21-Regulated Activation of the Akt Pathway Participates in the Protective Effects of H(2)S against Liver Ischemia-Reperfusion Injury. Biol Pharm Bull 41, 229-238 (2018).
33. Ye, M., et al. Exogenous hydrogen sulfide donor NaHS alleviates nickel-induced epithelial-mesenchymal transition and the migration of A549 cells by regulating TGF-beta1/Smad2/Smad3 signaling. Ecotoxicol Environ Saf 195, 110464 (2020).
34. Pavlovskiy, Y., Yashchenko, A. & Zayachkivska, O. H(2)S Donors Reverse Age-Related Gastric Malfunction Impaired Due to Fructose-Induced Injury via CBS, CSE, and TST Expression. Front Pharmacol 11, 1134 (2020).
35. Xu, M., Wu, Y.M., Li, Q., Wang, F.W. & He, R.R. Electrophysiological effects of hydrogen sulfide on guinea pig papillary muscles in vitro. Sheng Li Xue Bao 59, 215-220 (2007).
36. Wang, M., Guo, Z. & Wang, S. The effect of certain conditions in the regulation of cystathionine gamma-lyase by exogenous hydrogen sulfide in mammalian cells. Biochem Genet 51, 503-513 (2013).
37. Reiffenstein, R.J., Hulbert, W.C. & Roth, S.H. Toxicology of hydrogen sulfide. Annual review of pharmacology and toxicology 32, 109-134 (1992).
38. Yang, G., Cao, K., Wu, L. & Wang, R. Cystathionine gamma-lyase overexpression inhibits cell proliferation via a H2S-dependent modulation of ERK1/2 phosphorylation and p21Cip/WAK-1. J Biol Chem 279, 49199-49205 (2004).
39. Xie, W., et al. The H(2)S donor sulforaphane inhibits NLRP(3) inflammasome activation by inducing mitochondrial autophagy and mitigating CBS-H(2)S axis damage in in-vitro and in-vivo models of Parkinson's disease. Bioorg Chem 174, 109708 (2026).
40. Denu, J.M. & Tanner, K.G. Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation. Biochemistry 37, 5633-5642 (1998).
41. Schreck, R., Rieber, P. & Baeuerle, P.A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J 10, 2247-2258 (1991).
42. Kimura, Y. & Kimura, H. Hydrogen sulfide protects neurons from oxidative stress. FASEB J 18, 1165-1167 (2004).
43. Geng, B., et al. Endogenous hydrogen sulfide regulation of myocardial injury induced by isoproterenol. Biochemical and biophysical research communications 318, 756-763 (2004).
44. Chang, L., et al. Hydrogen sulfide inhibits myocardial injury induced by homocysteine in rats. Amino acids 34, 573-585 (2008).
45. Lu, M., Hu, L.F., Hu, G. & Bian, J.S. Hydrogen sulfide protects astrocytes against H(2)O(2)-induced neural injury via enhancing glutamate uptake. Free Radic Biol Med 45, 1705-1713 (2008).
46. Xu, Z.S., et al. Hydrogen sulfide protects MC3T3-E1 osteoblastic cells against H2O2-induced oxidative damage-implications for the treatment of osteoporosis. Free Radic Biol Med 50, 1314-1323 (2011).
47. Donatti, A.F., Soriano, R.N., Sabino, J.P. & Branco, L.G. Endogenous hydrogen sulfide in the rostral ventrolateral medulla/Botzinger complex downregulates ventilatory responses to hypoxia. Respir Physiol Neurobiol 200, 97-104 (2014).
48. Donatti, A.F., Soriano, R.N., Sabino, J.P. & Branco, L.G. Involvement of endogenous hydrogen sulfide (H2S) in the rostral ventrolateral medulla (RVLM) in hypoxia-induced hypothermia. Brain Res Bull 108, 94-99 (2014).
49. Kimura, H. Hydrogen sulfide and polysulfides as signaling molecules. Proc Jpn Acad Ser B Phys Biol Sci 91, 131-159 (2015).
50. Yuan, G., et al. H2S production by reactive oxygen species in the carotid body triggers hypertension in a rodent model of sleep apnea. Sci Signal 9, ra80 (2016).
51. Wen, Y.D., Wang, H. & Zhu, Y.Z. The Drug Developments of Hydrogen Sulfide on Cardiovascular Disease. Oxid Med Cell Longev 2018, 4010395 (2018).
52. Luo, Y., et al. Activation of the CaR-CSE/H2S pathway confers cardioprotection against ischemia-reperfusion injury. Exp Cell Res 398, 112389 (2021).
53. Mouli, K., et al. SOD1 at the Crossroads: Co-Overexpression of Canonical Antioxidant Response and Noncanonical Hydrogen Sulfide Generation Pathways in Down Syndrome, With Immune Cell Implications. Res Sq (2026).
54. Wang, M., Guo, Z. & Wang, S. Cystathionine gamma-lyase expression is regulated by exogenous hydrogen peroxide in the mammalian cells. Gene Expr 15, 235-241 (2012).
55. Blackstone, E., Morrison, M. & Roth, M.B. H2S induces a suspended animation-like state in mice. Science 308, 518 (2005).
56. Blackstone, E. & Roth, M.B. Suspended animation-like state protects mice from lethal hypoxia. Shock 27, 370-372 (2007).
57. Wang, R. Hydrogen sulfide: the third gasotransmitter in biology and medicine. Antioxid Redox Signal 12, 1061-1064 (2010).
58. Kimura, H. Hydrogen sulfide: its production, release and functions. Amino acids 41, 113-121 (2011).
59. Zhang, N., et al. Reduced hydrogen sulfide production contributes to adrenal insufficiency induced by hypoxia via modulation of NLRP3 inflammasome activation. Redox Rep 28, 2163354 (2023).
60. Peng, Y.J., et al. H2S mediates O2 sensing in the carotid body. Proc Natl Acad Sci U S A 107, 10719-10724 (2010).
61. Dombkowski, R.A., et al. Hydrogen sulfide (H(2)S) and hypoxia inhibit salmonid gastrointestinal motility: evidence for H(2)S as an oxygen sensor. J Exp Biol 214, 4030-4040 (2011).
62. Dombkowski, R.A., Doellman, M.M., Head, S.K. & Olson, K.R. Hydrogen sulfide mediates hypoxia-induced relaxation of trout urinary bladder smooth muscle. J Exp Biol 209, 3234-3240 (2006).
63. Yao, L.L., et al. Hydrogen sulfide protects cardiomyocytes from hypoxia/reoxygenation-induced apoptosis by preventing GSK-3beta-dependent opening of mPTP. Am J Physiol Heart Circ Physiol 298, H1310-1319 (2010).
64. Wang, Q., Liu, H.R., Mu, Q., Rose, P. & Zhu, Y.Z. S-propargyl-cysteine protects both adult rat hearts and neonatal cardiomyocytes from ischemia/hypoxia injury: the contribution of the hydrogen sulfide-mediated pathway. J Cardiovasc Pharmacol 54, 139-146 (2009).
65. Takemura, G., Ohno, M. & Fujiwara, H. [Ischemic heart disease and apoptosis]. Rinsho byori. The Japanese journal of clinical pathology 45, 606-613 (1997).
66. Yang, C., et al. Hydrogen sulfide protects against chemical hypoxia-induced cytotoxicity and inflammation in HaCaT cells through inhibition of ROS/NF-kappaB/COX-2 pathway. PLoS One 6, e21971 (2011).
67. Wang, H., Shi, X., Cheng, L., Han, J. & Mu, J. Hydrogen sulfide restores cardioprotective effects of remote ischemic preconditioning in aged rats via HIF-1alpha/Nrf2 signaling pathway. Korean J Physiol Pharmacol 25, 239-249 (2021).
68. Wang, M. Exogenous H2S Regulates CSE Expression in HUVECs under Hypoxic Conditions. Journal of Clinical, Medical, and Diagnostic Research 4, 1-8 (2026).
69. Zhao, W., Zhang, J., Lu, Y. & Wang, R. The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener. EMBO J 20, 6008-6016 (2001).
70. Hosoki, R., Matsuki, N. & Kimura, H. The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochemical and biophysical research communications 237, 527-531 (1997).
71. Huang, X.L., Zhou, X.H., Wei, P., Xian, X.H. & Ling, Y.L. [The role of hydrogen sulfide in acute lung injury during endotoxic shock and its relationship with nitric oxide and carbon monoxide]. Zhonghua Yi Xue Za Zhi 88, 2240-2245 (2008).
72. Wang, P., et al. [Effects of hydrogen sulfide on pulmonary surfactant in rats with acute lung injury induced by lipopolysccharide]. Zhongguo Ying Yong Sheng Li Xue Za Zhi 27, 485-489 (2011).
73. Fox, B., et al. Inducible hydrogen sulfide synthesis in chondrocytes and mesenchymal progenitor cells: is H2S a novel cytoprotective mediator in the inflamed joint? J Cell Mol Med 16, 896-910 (2012).
74. Zhang, H., et al. Hydrogen sulfide inhibits the development of atherosclerosis with suppressing CX3CR1 and CX3CL1 expression. PLoS One 7, e41147 (2012).
75. Tokuda, K., et al. Inhaled hydrogen sulfide prevents endotoxin-induced systemic inflammation and improves survival by altering sulfide metabolism in mice. Antioxid Redox Signal 17, 11-21 (2012).
76. George, L., Ramasamy, T., Sirajudeen, K. & Manickam, V. LPS-induced Apoptosis is Partially Mediated by Hydrogen Sulphide in RAW 264.7 Murine Macrophages. Immunol Invest 48, 451-465 (2019).
77. Chen, Y.H., et al. Hydrogen Sulfide Attenuated Sepsis-Induced Myocardial Dysfunction Through TLR4 Pathway and Endoplasmic Reticulum Stress. Front Physiol 12, 653601 (2021).
78. Perez-Torres, I., et al. Deodorized Garlic Decreases Oxidative Stress Caused by Lipopolysaccharide in Rat Heart through Hydrogen Sulfide: Preliminary Findings. Int J Mol Sci 23(2022).
79. Li, X., Yin, X., Pang, J., Chen, Z. & Wen, J. Hydrogen sulfide inhibits lipopolysaccharide-based neuroinflammation-induced astrocyte polarization after cerebral ischemia/reperfusion injury. Eur J Pharmacol 949, 175743 (2023).
80. Shahid, A., Chambers, S., Scott-Thomas, A., Zawari, M. & Bhatia, M. Anti-Inflammatory Effects of Alpha-Lipoic Acid Modulate Cystathionine-gamma-Lyase Expression in RAW 264.7 Macrophages. Int J Mol Sci 27(2026).
81. Pahl, H.L. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18, 6853-6866 (1999).
82. Baeuerle, P.A. & Baltimore, D. NF-kappa B: ten years after. Cell 87, 13-20 (1996).
83. Oh, G.S., et al. Hydrogen sulfide inhibits nitric oxide production and nuclear factor-kappaB via heme oxygenase-1 expression in RAW264.7 macrophages stimulated with lipopolysaccharide. Free Radic Biol Med 41, 106-119 (2006).
84. Zhu, X.Y., Liu, S.J., Liu, Y.J., Wang, S. & Ni, X. Glucocorticoids suppress cystathionine gamma-lyase expression and H2S production in lipopolysaccharide-treated macrophages. Cell Mol Life Sci 67, 1119-1132 (2010).
85. Li, L., Whiteman, M. & Moore, P.K. Dexamethasone inhibits lipopolysaccharide-induced hydrogen sulphide biosynthesis in intact cells and in an animal model of endotoxic shock. Journal of cellular and molecular medicine 13, 2684-2692 (2009).
86. Moon, E.Y., Lee, J.H., Lee, J.W., Song, J.H. & Pyo, S. ROS/Epac1-mediated Rap1/NF-kappaB activation is required for the expression of BAFF in Raw264.7 murine macrophages. Cell Signal 23, 1479-1488 (2011).
87. Gong, Q.H., et al. S-propargyl-cysteine, a novel hydrogen sulfide-modulated agent, attenuates lipopolysaccharide-induced spatial learning and memory impairment: involvement of TNF signaling and NF-kappaB pathway in rats. Brain Behav Immun 25, 110-119 (2011).
88. Pan, L.L., Liu, X.H., Gong, Q.H. & Zhu, Y.Z. S-Propargyl-cysteine (SPRC) attenuated lipopolysaccharide-induced inflammatory response in H9c2 cells involved in a hydrogen sulfide-dependent mechanism. Amino Acids 41, 205-215 (2011).
89. Luo, Z., et al. Hijacking the Hydrogen Sulfide Axis: A Novel 4-Trifluoromethylquinoline Derivative Suppresses Glioblastoma via Cystathionine gamma-Lyase Suppression. J Med Chem 69, 3457-3476 (2026).
90. Huang, X.L., et al. Role of endogenous hydrogen sulfide in pulmonary hypertension induced by lipopolysaccharide. Sheng li xue bao : [Acta physiologica Sinica] 60, 211-215 (2008).
91. Zhang, J., Xie, Y., Xu, Y. & Shao, C. Suppression of endogenous hydrogen sulfide contributes to the radiation-induced bystander effects on hypoxic HepG2 cells. Radiat Res 178, 395-402 (2012).
92. Wang, M., Guo, Z. & Wang, S. The binding site for the transcription factor, NF-kappaB, on the cystathionine gamma-lyase promoter is critical for LPS-induced cystathionine gamma-lyase expression. Int J Mol Med 34, 639-645 (2014).
93. Wang, Y., et al. H(2)S mediates apoptosis in response to inflammation through PI3K/Akt/NFkappaB signaling pathway. Biotechnol Lett 42, 375-387 (2020).
94. Cornwell, A., Fedotova, S., Cowan, S. & Badiei, A. Cystathionine gamma-lyase and hydrogen sulfide modulates glucose transporter Glut1 expression via NF-kappaB and PI3k/Akt in macrophages during inflammation. PLoS One 17, e0278910 (2022).
95. Zhuang, R., et al. Exogenous hydrogen sulfide inhibits oral mucosal wound-induced macrophage activation via the NF-kappaB pathway. Oral Dis 24, 793-801 (2018).
96. Zheng, Y., et al. Lipopolysaccharide regulates biosynthesis of cystathionine gamma-lyase and hydrogen sulfide through Toll-like receptor-4/p38 and Toll-like receptor-4/NF-kappaB pathways in macrophages. In Vitro Cell Dev Biol Anim 49, 679-688 (2013).
97. Rao, C.Y., et al. H2S mitigates severe acute pancreatitis through the PI3K/AKT-NF-kappaB pathway in vivo. World J Gastroenterol 21, 4555-4563 (2015).
98. Zhang, D., et al. Endogenous hydrogen sulfide sulfhydrates IKKbeta at cysteine 179 to control pulmonary artery endothelial cell inflammation. Clin Sci (Lond) 133, 2045-2059 (2019).
99. Wang, M. TNFalpha regulates the expression of the CSE gene in HUVEC. Exp Ther Med 22, 1233 (2021).
100. Hu, H.J., Jiang, Z.S., Zhou, S.H. & Liu, Q.M. Hydrogen sulfide suppresses angiotensin II-stimulated endothelin-1 generation and subsequent cytotoxicity-induced endoplasmic reticulum stress in endothelial cells via NF-kappaB. Mol Med Rep 14, 4729-4740 (2016).
101. Kimura, H. The physiological role of hydrogen sulfide and beyond. Nitric Oxide 41, 4-10 (2014).
102. Bourque, C., et al. H(2)S protects lipopolysaccharide-induced inflammation by blocking NFkappaB transactivation in endothelial cells. Toxicol Appl Pharmacol 338, 20-29 (2018).
103. Wang, X.L., et al. Endogenous Hydrogen Sulfide Ameliorates NOX4 Induced Oxidative Stress in LPS-Stimulated Macrophages and Mice. Cell Physiol Biochem 47, 458-474 (2018).
104. Liu, Y., et al. Exogenous H(2)S Protects Colon Cells in Ulcerative Colitis by Inhibiting NLRP3 and Activating Autophagy. DNA Cell Biol 40, 748-756 (2021).
105. Duan, J., et al. Methionine Restriction Prevents Lipopolysaccharide-Induced Acute Lung Injury via Modulating CSE/H(2)S Pathway. Nutrients 14(2022).